Zivo Bioscience, Inc. - ZIVO
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | History | Reduced | 801,870 | 1,042 | 0.02% | 0.04% | 1 | -222,000 | -21.68% | Q3 2023 | Nov 14, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | History | Added to | 272,851 | 360 | 0.0% | 0.0% | 2 | +63 | 0.02% | Q3 2023 | Nov 13, 2023 |
| VANGUARD GROUP INC | History | Added to | 130,866 | 170 | 0.0% | 0.0% | 3 | +14,536 | 12.5% | Q3 2023 | Dec 18, 2023 |
| WELLS FARGO & COMPANY/MN | History | Added to | 11,328 | 14 | 0.0% | 0.0% | 4 | +10 | 0.09% | Q3 2023 | Nov 13, 2023 |
| Tower Research Capital LLC (TRC) | History | New | 5,351 | 6 | 0.0% | — | 5 | +5,351 | New | Q3 2023 | Nov 14, 2023 |
| BARTLETT & CO. WEALTH MANAGEMENT LLC | History | No change | 1,000 | 1 | 0.0% | 0.0% | 6 | 0 | 0.0% | Q3 2023 | Feb 14, 2024 |
| JPMORGAN CHASE & CO | History | Reduced | 9 | 0 | — | — | — | -91 | -91.0% | Q3 2023 | Nov 14, 2023 |
| PNC FINANCIAL SERVICES GROUP, INC. | History | No change | 629 | 0 | — | 0.0% | — | 0 | 0.0% | Q3 2023 | Nov 13, 2023 |
| ROYAL BANK OF CANADA | History | No change | 170 | 0 | — | — | — | 0 | 0.0% | Q3 2023 | Nov 14, 2023 |